Reversible Cerebral Vasoconstriction Syndrome in Early Pregnancy Treated with Endovascular Therapy
- PMID: 37502693
- PMCID: PMC10370675
- DOI: 10.5797/jnet.cr.2019-0108
Reversible Cerebral Vasoconstriction Syndrome in Early Pregnancy Treated with Endovascular Therapy
Abstract
Objective: We report a case of reversible cerebral vasoconstriction syndrome (RCVS) that occurred during early pregnancy and improved by endovascular therapy (EVT).
Case presentation: A 30-year-old Japanese woman at 8 weeks' gestation presented with sudden occipital headache followed by left hemiparesis and convulsion. MRI on admission revealed acute infarction in the distribution of the right posterior cerebral artery (PCA), and MRA demonstrated multi-segmental vasoconstrictions in the posterior circulation. Since the episode and image findings were suggestive of RCVS and the patient was in the organogenesis period, intravenous magnesium sulfate was administered as a vasodilator. Her level of consciousness improved temporarily; however, she suddenly fell into a stupor on day 4 of the illness. Emergency MRI demonstrated a fresh infarction in the left side of pons, and the poorer visualization of the posterior circulation. We proposed selective intra-arterial infusion of nicardipine 1 mg over 1 minute through an indwelling microcatheter in the middle of the basilar artery. The left superior cerebellar artery (SCA) and P1 blood flow improved after the procedure. Her symptoms improved gradually, and follow-up MRA performed on day 15 was almost normal. Hence, we established a definite diagnosis of RCVS. She was discharged to recovery phase rehabilitation hospital with modified Rankin Scale 4 and National Institute of Health Stroke Scale (NIHSS) 5.
Conclusion: RCVS can occur in early pregnancy period, and EVT is a potential therapeutic option for RCVS in this condition.
Keywords: early pregnancy; endovascular therapy; intra-arterial infusion of nicardipine; reversible vasoconstriction syndrome.
©2020 The Japanese Society for Neuroendovascular Therapy.
Conflict of interest statement
Nobuyuki Sakai received lecture fees from Stryker Japan K.K. and Biomedical Solutions, Inc.; Nobuyuki Sakai received a research grant from TERUMO Corporation; Nobuyuki Sakai received consigned research fund from DAIICHI SANKYO COMPANY, LIMITED, TERUMO Corporation, and JIMRO Co., Ltd. The remaining authors have no conflict of interest related to this work.
Figures





References
-
- Ducros A: Reversible cerebral vasoconstriction syndrome. Lancet Neurol 2012; 11: 906–917. - PubMed
-
- Ducros A, Wolff V: The typical thunderclap headache of reversible cerebral vasoconstriction syndrome and its various triggers. Headache 2016; 56: 657–673. - PubMed
-
- The 2007 Recommendations of the International Commission on Radiological Protection . ICRP publication 103. Ann ICRP 2007; 37: 1–332. - PubMed
-
- Tanaka T, Sadatoh A, Hayakawa M, et al. : Endovascular treatment of stroke during pregnancy: Measuring the radiation exposure dose of lower abdomen using the human body phantom. JNET J Neuroendovasc Ther 2013; 7: 243–251.